Annual revenue:
$434.43M+$374.43M(+624.06%)Summary
- As of today (September 16, 2025), PTGX annual revenue is $434.43 million, with the most recent change of +$374.43 million (+624.06%) on December 31, 2024.
- During the last 3 years, PTGX annual revenue has risen by +$407.08 million (+1488.01%).
- PTGX annual revenue is now at all-time high.
Performance
PTGX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$5.55M-$22.77M(-80.42%)Summary
- As of today (September 16, 2025), PTGX quarterly revenue is $5.55 million, with the most recent change of -$22.77 million (-80.42%) on June 30, 2025.
- Over the past year, PTGX quarterly revenue has increased by +$1.38 million (+33.09%).
- PTGX quarterly revenue is now -97.82% below its all-time high of $254.95 million, reached on March 31, 2024.
Performance
PTGX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$209.18M+$1.38M(+0.66%)Summary
- As of today (September 16, 2025), PTGX TTM revenue is $209.18 million, with the most recent change of +$1.38 million (+0.66%) on June 30, 2025.
- Over the past year, PTGX TTM revenue has dropped by -$109.94 million (-34.45%).
- PTGX TTM revenue is now -51.85% below its all-time high of $434.43 million, reached on December 31, 2024.
Performance
PTGX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PTGX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +624.1% | +33.1% | -34.5% |
| 3 y3 years | +1488.0% | +545.6% | +359.9% |
| 5 y5 years | +10000.0% | -10.8% | +1150.8% |
PTGX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1534.4% | -97.8% | >+9999.0% | -51.9% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -97.8% | >+9999.0% | -51.9% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -97.8% | +167.7% | -51.9% | >+9999.0% |
PTGX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $5.55M(-80.4%) | $209.18M(+0.7%) |
| Mar 2025 | - | $28.32M(-83.4%) | $207.80M(-52.2%) |
| Dec 2024 | $434.43M(+624.1%) | $170.64M(+3550.0%) | $434.43M(+34.2%) |
| Sep 2024 | - | $4.67M(+12.2%) | $323.80M(+1.5%) |
| Jun 2024 | - | $4.17M(-98.4%) | $319.12M(+1.3%) |
| Mar 2024 | - | $254.95M(+324.9%) | $314.95M(+424.9%) |
| Dec 2023 | $60.00M(+125.7%) | $60.00M(>+9900.0%) | $60.00M(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2023 | - | $0.00(0.0%) | $859.00K(-96.8%) |
| Dec 2022 | $26.58M(-2.8%) | $0.00(0.0%) | $26.58M(-24.5%) |
| Sep 2022 | - | $0.00(-100.0%) | $35.20M(-22.6%) |
| Jun 2022 | - | $859.00K(-96.7%) | $45.48M(-3.0%) |
| Mar 2022 | - | $25.72M(+198.5%) | $46.89M(+71.4%) |
| Dec 2021 | $27.36M(-4.4%) | $8.62M(-16.2%) | $27.36M(+12.2%) |
| Sep 2021 | - | $10.29M(+354.1%) | $24.39M(-10.4%) |
| Jun 2021 | - | $2.27M(-63.4%) | $27.22M(-12.7%) |
| Mar 2021 | - | $6.19M(+9.5%) | $31.17M(+8.9%) |
| Dec 2020 | $28.63M | $5.65M(-56.9%) | $28.63M(+11.4%) |
| Sep 2020 | - | $13.11M(+110.9%) | $25.70M(+53.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $6.22M(+70.5%) | $16.72M(+621.5%) |
| Mar 2020 | - | $3.65M(+34.1%) | $2.32M(+903.5%) |
| Dec 2019 | $231.00K(-99.3%) | $2.72M(-34.3%) | $231.00K(-271.1%) |
| Sep 2019 | - | $4.14M(-150.6%) | -$135.00K(-107.3%) |
| Jun 2019 | - | -$8.19M(-624.9%) | $1.84M(-91.5%) |
| Mar 2019 | - | $1.56M(-33.7%) | $21.70M(-29.8%) |
| Dec 2018 | $30.93M(+54.1%) | $2.35M(-61.5%) | $30.93M(-22.4%) |
| Sep 2018 | - | $6.12M(-47.6%) | $39.85M(-6.3%) |
| Jun 2018 | - | $11.67M(+8.3%) | $42.52M(+37.8%) |
| Mar 2018 | - | $10.78M(-4.4%) | $30.84M(+53.7%) |
| Dec 2017 | $20.06M(>+9900.0%) | $11.28M(+28.5%) | $20.06M(+128.5%) |
| Sep 2017 | - | $8.78M(>+9900.0%) | $8.78M(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | - | - |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual revenue?
- What is the all time high annual revenue for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual revenue year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM revenue?
- What is the all time high TTM revenue for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM revenue year-on-year change?
What is Protagonist Therapeutics, Inc. annual revenue?
The current annual revenue of PTGX is $434.43M
What is the all time high annual revenue for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual revenue is $434.43M
What is Protagonist Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, PTGX annual revenue has changed by +$374.43M (+624.06%)
What is Protagonist Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of PTGX is $5.55M
What is the all time high quarterly revenue for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly revenue is $254.95M
What is Protagonist Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, PTGX quarterly revenue has changed by +$1.38M (+33.09%)
What is Protagonist Therapeutics, Inc. TTM revenue?
The current TTM revenue of PTGX is $209.18M
What is the all time high TTM revenue for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM revenue is $434.43M
What is Protagonist Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, PTGX TTM revenue has changed by -$109.94M (-34.45%)